Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy

Autor: Maeda, Shimpei a, b, Mederos, Michael A. b, Chawla, Akhil c, Moore, Alexandra M. b, Shoucair, Sami a, Yin, Lingdi a, Burkhart, Richard A. a, Cameron, John L. a, Park, Joon Y. b, Girgis, Mark D. b, Wainberg, Zev A. d, Hines, O. Joe b, Fernandez-Del Castillo, Carlos e, Qadan, Motaz e, Lillemoe, Keith D. e, Ferrone, Cristina R. e, He, Jin a, Wolfgang, Christopher L. a, Burns, William R. a, Yu, Jun a, Donahue, Timothy R. b, ∗
Zdroj: In Surgery May 2022 171(5):1379-1387
Databáze: ScienceDirect